Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ajanta Pharma Ltd. Director's Dealing 2026

May 29, 2026

59171_rns_2026-05-29_48a21828-2071-4bd9-9d4f-33ae3b5a4669.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

25th May 2026

Aayush Agrawal

Level 6, Gala Impecca,
Next to Courtyard, Marriott Hotel,
Andheri Kurla Road, J B Nagar,
Andheri (East),
Mumbai - 400059.

BSE Limited,
Phiroze Jeejeeboy Towers,
Dalal Street,
Mumbai - 400 001

National Stock Exchange of India
Exchange Plaza, 5th Floor, Plot no. C/1, G Block,
Bandra Kurla Complex, Bandra (East),
Mumbai - 400 051

Re: Disclosure of Release of Pledge under SEBI (SAST) Regulations, 2011

(Ajanta Pharma Limited Scrip Code: BSE - AJANTPHARM 532331 & NSE - AJANTPHARM EQ)

This is to inform that I, being promoter of Ajanta Pharma Limited, have released pledge on 1,92,500 shares. The reason for release of pledge is loan repaid.

Please find enclosed herewith prescribed form under Regulation 31(1) & 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 giving details of Release of pledge on the shares of Ajanta Pharma Limited.

Kindly acknowledge the receipt and take on your records.

Thanking You,
Yours faithfully,

Aayush Agrawal
(Trustee Aayush Agrawal Trust)

c.c.:
The Company Secretary
Ajanta Pharma Limited
Ajanta Tower, 54-A,
M Vasanji Road,
Chakala, Andheri (E),
Mumbai- 400 093

Encl.: a/a


Format for disclosure by the Promoter(s) to the stock exchange and to the Target Company for encumbrance of shares/ Invocation of encumbrance/ release of encumbrance, in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011

Name of the Target Company (TC): Ajanta Pharma Limited

Name of the Stock Exchange where the shares of the target company are listed: BSE & NSE

Date of reporting: 25.05.2026

Name of the promoter or PAC on whose shares encumbrance has been created/ released/invoked : Aayush Agrawal, trustee Aayush Agrawal Trust

Details of the release and creation of encumbrance: Release of pledge

Name of the promoter(s) or PACs with him(*) Promoter holding in the target company (1) Promoter holding already encumbered (2) Details of events pertaining to encumbrance (3) Post event holding of encumbered shares (creation [(2)+(3)]/ release[(2)-(3)]/ Invocation[(1)-(3)])
Number % of total share capital Number % of total share capital Type of event (creation/release/invocation) Date of creation/release/invocation of encumbrance Type of encumbrance (pledge/lien/no e disposal undertaking/ others) Reasons for encumbrance ** Number % of total share capital Name of the entity in whose favor shares encumbered *** Number % of total share capital
Gabs Investments Pvt Ltd 1,25,88,393 10.08 - - - - - - - - - - -
Yogesh M Agrawal, trustee Yogesh Agrawal Trust 1,80,78,147 14.47 - - - - - - - - - - -
Mannalal B Agrawal 0 0.00 - - - - - - - - - - -
Rajesh M Agrawal, trustee Rajesh Agrawal Trust 1,80,78,148 14.47 - - - - - - - - - - -
Ravi P Agrawal, trustee Ravi Agrawal Trust 1,62,42,904 13.00 60,63,920 4.85 - - - - - - - 60,63,920 4.85
Ravi P. Agrawal 2,85,000 0.23 - - - - - - - - - - -
Aayush M Agrawal, trustee Aayush Agrawal Trust 1,41,12,924 11.30 87,81,662 7.03 Pledge Release 22-May-26 Pledge loan Repaid 1,92,500 0.15 Ashika Stock Services Ltd 85,89,162 6.87
Aayush M. Agrawal 30,000 0.02 - - - - - - - - - - -
Ganga Exports represented by its partners Yogesh Agrawal, Rajesh Agrawal & Ravi Agrawal 33,48,261 2.68 - - - - - - - - - - -

Signature of the Authorised Signatory: _______
Date:25/05/2026

*The names of all the promoters, their shareholding in the target company and their pledged shareholding as on the reporting date should appear in the table irrespective of whether they are reporting on the date of event or not.
** For example, for the purpose of collateral for loans taken by the company, personal borrowing, third party pledge, etc.
*** This would include name of both the lender and the trustee who may hold shares directly or on behalf of the lender.